{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T12:34:53Z","timestamp":1794573293391,"version":"4.9.1"},"reference-count":126,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.antiviral.2016.11.006","type":"journal-article","created":{"date-parts":[[2016,11,11]],"date-time":"2016-11-11T03:01:35Z","timestamp":1478833295000},"page":"82-92","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":322,"special_numbering":"C","title":["T-cell immunity of SARS-CoV: Implications for vaccine development against MERS-CoV"],"prefix":"10.1016","volume":"137","author":[{"given":"William J.","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kefang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjie","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George F.","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2016.11.006_bib1","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1093\/infdis\/jit609","article-title":"Evaluation of serologic and antigenic relationships between Middle Eastern respiratory syndrome coronavirus and other coronaviruses to develop vaccine platforms for the rapid response to emerging coronaviruses","volume":"209","author":"Agnihothram","year":"2014","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.antiviral.2016.11.006_bib2","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1084\/jem.189.1.169","article-title":"DNA vaccination: transfection and activation of dendritic cells as key events for immunity","volume":"189","author":"Akbari","year":"1999","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.antiviral.2016.11.006_bib3","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1093\/cid\/ciu359","article-title":"Hospital-associated outbreak of Middle East respiratory syndrome coronavirus: a serologic, epidemiologic, and clinical description","volume":"59","author":"Al-Abdallat","year":"2014","journal-title":"Clin. Infect. Dis."},{"issue":"6","key":"10.1016\/j.antiviral.2016.11.006_bib4","doi-asserted-by":"crossref","DOI":"10.3201\/eid2206.160010","article-title":"Antibody response and disease severity in healthcare worker MERS survivors","volume":"22","author":"Alshukairi","year":"2016","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.antiviral.2016.11.006_bib5","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.3201\/eid2209.151164","article-title":"Feasibility of using convalescent plasma immunotherapy for MERS-CoV infection, Saudi Arabia","volume":"22","author":"Arabi","year":"2016","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.antiviral.2016.11.006_bib6","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1107\/S0907444905013090","article-title":"High-resolution structure of HLA-A*1101 in complex with SARS nucleocapsid peptide","volume":"61","author":"Blicher","year":"2005","journal-title":"Acta Crystallogr. D. Biol. Crystallogr."},{"key":"10.1016\/j.antiviral.2016.11.006_bib7","doi-asserted-by":"crossref","first-page":"8692","DOI":"10.1128\/JVI.00527-07","article-title":"Interferon-mediated immunopathological events are associated with atypical innate and adaptive immune responses in patients with severe acute respiratory syndrome","volume":"81","author":"Cameron","year":"2007","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2016.11.006_bib8","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.jinf.2013.03.015","article-title":"Cross-reactive antibodies in convalescent SARS patients' sera against the emerging novel human coronavirus EMC (2012) by both immunofluorescent and neutralizing antibody tests","volume":"67","author":"Chan","year":"2013","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.antiviral.2016.11.006_bib9","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.chom.2016.01.007","article-title":"Dysregulated type I interferon and inflammatory monocyte-macrophage responses cause lethal pneumonia in SARS-CoV-infected mice","volume":"19","author":"Channappanavar","year":"2016","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.antiviral.2016.11.006_bib10","doi-asserted-by":"crossref","first-page":"11034","DOI":"10.1128\/JVI.01505-14","article-title":"Virus-specific memory CD8 T cells provide substantial protection from lethal severe acute respiratory syndrome coronavirus infection","volume":"88","author":"Channappanavar","year":"2014","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2016.11.006_bib11","doi-asserted-by":"crossref","first-page":"591","DOI":"10.4049\/jimmunol.175.1.591","article-title":"Response of memory CD8+ T cells to severe acute respiratory syndrome (SARS) coronavirus in recovered SARS patients and healthy individuals","volume":"175","author":"Chen","year":"2005","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.antiviral.2016.11.006_bib12","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1128\/JVI.01281-09","article-title":"Cellular immune responses to severe acute respiratory syndrome coronavirus (SARS-CoV) infection in senescent BALB\/c mice: CD4+ T cells are important in control of SARS-CoV infection","volume":"84","author":"Chen","year":"2010","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2016.11.006_bib13","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s13238-014-0026-3","article-title":"SARS coronavirus papain-like protease inhibits the type I interferon signaling pathway through interaction with the STING-TRAF3-TBK1 complex","volume":"5","author":"Chen","year":"2014","journal-title":"Protein Cell"},{"key":"10.1016\/j.antiviral.2016.11.006_bib14","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1177\/039463201002300115","article-title":"Identification of SARS-COV spike protein-derived and HLA-A2-restricted human CTL epitopes by using a new muramyl dipeptidederivative adjuvant","volume":"23","author":"Chen","year":"2010","journal-title":"Int. J. Immunopathol. Pharmacol."},{"key":"10.1016\/j.antiviral.2016.11.006_bib15","doi-asserted-by":"crossref","first-page":"6070","DOI":"10.1016\/j.vaccine.2007.05.025","article-title":"Induction of T-cell response by a DNA vaccine encoding a novel HLA-A*0201 severe acute respiratory syndrome coronavirus epitope","volume":"25","author":"Cheung","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2016.11.006_bib16","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1093\/infdis\/jiv380","article-title":"Middle East respiratory syndrome coronavirus efficiently infects human primary T Lymphocytes and activates the extrinsic and intrinsic apoptosis pathways","volume":"213","author":"Chu","year":"2016","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.antiviral.2016.11.006_bib17","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1093\/cid\/civ951","article-title":"Viral shedding and antibody response in 37 patients with Middle East respiratory syndrome coronavirus infection","volume":"62","author":"Corman","year":"2016","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.antiviral.2016.11.006_bib18","doi-asserted-by":"crossref","first-page":"11297","DOI":"10.1128\/JVI.01498-14","article-title":"Rooting the phylogenetic tree of Middle East respiratory syndrome coronavirus by characterization of a conspecific virus from an African bat","volume":"88","author":"Corman","year":"2014","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2016.11.006_bib19","doi-asserted-by":"crossref","first-page":"10473","DOI":"10.1073\/pnas.1510199112","article-title":"Prophylactic and postexposure efficacy of a potent human monoclonal antibody against MERS coronavirus","volume":"112","author":"Corti","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.antiviral.2016.11.006_bib20","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.3201\/eid2112.151232","article-title":"Characteristics of traveler with Middle East respiratory syndrome, China, 2015","volume":"21","author":"Da Guan","year":"2015","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.antiviral.2016.11.006_bib118","doi-asserted-by":"crossref","first-page":"2648","DOI":"10.1039\/b300707c","article-title":"The HLA-A2-supermotif: a QSAR definition","volume":"1","author":"Doytchinova","year":"2003","journal-title":"Organ. Biomol. Chem."},{"key":"10.1016\/j.antiviral.2016.11.006_bib21","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/nrmicro2090","article-title":"The spike protein of SARS-CoV\u2013a target for vaccine and therapeutic development","volume":"7","author":"Du","year":"2009","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.antiviral.2016.11.006_bib22","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.jinf.2013.05.002","article-title":"Antibodies induced by receptor-binding domain in spike protein of SARS-CoV do not cross-neutralize the novel human coronavirus hCoV-EMC","volume":"67","author":"Du","year":"2013","journal-title":"J.\u00a0Infect."},{"key":"10.1016\/j.antiviral.2016.11.006_bib23","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1586\/14760584.2016.1167603","article-title":"Vaccines for the prevention against the threat of MERS-CoV","volume":"15","author":"Du","year":"2016","journal-title":"Expert Rev. Vac."},{"key":"10.1016\/j.antiviral.2016.11.006_bib24","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1089\/vim.2009.0090","article-title":"A\u00a0219-mer CHO-expressing receptor-binding domain of SARS-CoV S protein induces potent immune responses and protective immunity","volume":"23","author":"Du","year":"2010","journal-title":"Viral Immunol."},{"key":"10.1016\/j.antiviral.2016.11.006_bib25","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.bbrc.2009.05.003","article-title":"Antigenicity and immunogenicity of SARS-CoV S protein receptor-binding domain stably expressed in CHO cells","volume":"384","author":"Du","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.antiviral.2016.11.006_bib26","doi-asserted-by":"crossref","first-page":"948","DOI":"10.4049\/jimmunol.180.2.948","volume":"180","author":"Du","year":"2008","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.antiviral.2016.11.006_bib27","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1007\/s00705-009-0409-6","article-title":"Characterization of SARS-CoV-specific memory T cells from recovered individuals 4 years after infection","volume":"154","author":"Fan","year":"2009","journal-title":"Arch. Virol."},{"key":"10.1016\/j.antiviral.2016.11.006_bib28","doi-asserted-by":"crossref","first-page":"e88716","DOI":"10.1371\/journal.pone.0088716","article-title":"Distinct immune response in two MERS-CoV-infected patients: can we go from bench to bedside?","volume":"9","author":"Faure","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.antiviral.2016.11.006_bib29","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.cimid.2007.05.009","article-title":"Towards our understanding of SARS-CoV, an emerging and devastating but quickly conquered virus","volume":"30","author":"Feng","year":"2007","journal-title":"Comp. Immunol. Microbiol. Infect. Dis."},{"key":"10.1016\/j.antiviral.2016.11.006_bib30","doi-asserted-by":"crossref","first-page":"e1000849","DOI":"10.1371\/journal.ppat.1000849","article-title":"SARS-CoV pathogenesis is regulated by a STAT1 dependent but a type I, II and III interferon receptor independent mechanism","volume":"6","author":"Frieman","year":"2010","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2016.11.006_bib31","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1084\/jem.20050828","article-title":"Multiple organ infection and the pathogenesis of SARS","volume":"202","author":"Gu","year":"2005","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.antiviral.2016.11.006_bib32","doi-asserted-by":"crossref","first-page":"3718","DOI":"10.1128\/JCM.43.8.3718-3726.2005","article-title":"Identification of immunodominant epitopes on the membrane protein of the severe acute respiratory syndrome-associated coronavirus","volume":"43","author":"He","year":"2005","journal-title":"J.\u00a0Clin. Microbiol."},{"issue":"Suppl.\u00a01","key":"10.1016\/j.antiviral.2016.11.006_bib33","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.26719\/2013.19.supp1.S12","article-title":"Novel coronavirus infections in Jordan, April 2012: epidemiological findings from a retrospective investigation","volume":"19","author":"Hijawi","year":"2013","journal-title":"East Mediterr Health J"},{"key":"10.1016\/j.antiviral.2016.11.006_bib34","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.antiviral.2013.08.015","article-title":"From SARS to MERS: 10 years of research on highly pathogenic human coronaviruses","volume":"100","author":"Hilgenfeld","year":"2013","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2016.11.006_bib35","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1111\/j.1469-0691.2004.01009.x","article-title":"Chronological evolution of IgM, IgA, IgG and neutralisation antibodies after infection with SARS-associated coronavirus","volume":"10","author":"Hsueh","year":"2004","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.antiviral.2016.11.006_bib119","doi-asserted-by":"crossref","first-page":"6981","DOI":"10.1016\/j.vaccine.2007.06.047","article-title":"Priming with SARS CoV S DNA and boosting with SARS CoV S epitopes specific for CD4+ and CD8+ T cells promote cellular immune responses","volume":"25","author":"Huang","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2016.11.006_bib36","doi-asserted-by":"crossref","first-page":"33612","DOI":"10.1038\/srep33612","article-title":"Improved transgenic mouse model for studying HLA class I antigen presentation","volume":"6","author":"Huang","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.antiviral.2016.11.006_bib37","doi-asserted-by":"crossref","first-page":"e62416","DOI":"10.1371\/journal.pone.0062416","article-title":"Identification of residues of SARS-CoV nsp1 that differentially affect inhibition of gene expression and antiviral signaling","volume":"8","author":"Jauregui","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.antiviral.2016.11.006_bib38","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/imr.12005","article-title":"Structural insights into key sites of vulnerability on HIV-1 Env and influenza HA","volume":"250","author":"Julien","year":"2012","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.antiviral.2016.11.006_bib39","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1093\/cid\/ciu635","article-title":"Clinical and laboratory findings of the first imported case of Middle East respiratory syndrome coronavirus to the United States","volume":"59","author":"Kapoor","year":"2014","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.antiviral.2016.11.006_bib40","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.antiviral.2009.09.004","article-title":"Efficient induction of cytotoxic T lymphocytes specific for severe acute respiratory syndrome (SARS)-associated coronavirus by immunization with surface-linked liposomal peptides derived from a non-structural polyprotein 1a","volume":"84","author":"Kohyama","year":"2009","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2016.11.006_bib41","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1128\/JVI.01782-06","article-title":"Severe acute respiratory syndrome coronavirus open reading frame (ORF) 3b, ORF 6, and nucleocapsid proteins function as interferon antagonists","volume":"81","author":"Kopecky-Bromberg","year":"2007","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2016.11.006_bib42","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1056\/NEJMoa030781","article-title":"A\u00a0novel coronavirus associated with severe acute respiratory syndrome","volume":"348","author":"Ksiazek","year":"2003","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.antiviral.2016.11.006_bib43","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/nm1267","article-title":"A\u00a0crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury","volume":"11","author":"Kuba","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.antiviral.2016.11.006_bib44","doi-asserted-by":"crossref","first-page":"e112602","DOI":"10.1371\/journal.pone.0112602","article-title":"Tailoring subunit vaccine immunity with adjuvant combinations and delivery routes using the Middle East respiratory coronavirus (MERS-CoV) receptor-binding domain as an antigen","volume":"9","author":"Lan","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.antiviral.2016.11.006_bib45","doi-asserted-by":"crossref","first-page":"8638","DOI":"10.1128\/JVI.01055-13","volume":"87","author":"Lau","year":"2013","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2016.11.006_bib46","doi-asserted-by":"crossref","first-page":"221","DOI":"10.4049\/jimmunol.114.1_Part_1.221","article-title":"Immunopathology of mouse hepatitis virus type 3 infection. Role of humoral and cell-mediated immunity in resistance mechanisms","volume":"114","author":"Le Prevost","year":"1975","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.antiviral.2016.11.006_bib47","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1086\/422040","article-title":"Antibody response of patients with severe acute respiratory syndrome (SARS) targets the viral nucleocapsid","volume":"190","author":"Leung","year":"2004","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.antiviral.2016.11.006_bib48","doi-asserted-by":"crossref","first-page":"5490","DOI":"10.4049\/jimmunol.181.8.5490","article-title":"T\u00a0cell responses to whole SARS coronavirus in humans","volume":"181","author":"Li","year":"2008","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.antiviral.2016.11.006_bib49","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1126\/science.1116480","article-title":"Structure of SARS coronavirus spike receptor-binding domain complexed with receptor","volume":"309","author":"Li","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2016.11.006_bib50","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.antiviral.2016.03.003","article-title":"Recombinant duck enteritis viruses expressing major structural proteins of the infectious bronchitis virus provide protection against infectious bronchitis in chickens","volume":"130","author":"Li","year":"2016","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2016.11.006_bib51","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1126\/science.1118391","article-title":"Bats are natural reservoirs of SARS-like coronaviruses","volume":"310","author":"Li","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2016.11.006_bib52","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1038\/cr.2015.113","article-title":"A\u00a0humanized neutralizing antibody against MERS-CoV targeting the receptor-binding domain of the spike protein","volume":"25","author":"Li","year":"2015","journal-title":"Cell Res."},{"key":"10.1016\/j.antiviral.2016.11.006_bib53","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/sj.cr.7290158","article-title":"Identification of an epitope of SARS-coronavirus nucleocapsid protein","volume":"13","author":"Lin","year":"2003","journal-title":"Cell Res."},{"key":"10.1016\/j.antiviral.2016.11.006_bib54","first-page":"8","article-title":"Functional and structural definition of a clustering region of HLA-A2-restricted cytotoxic T lymphocyte epitopes","volume":"29","author":"Liu","year":"2011","journal-title":"Sci. Tech. Rev. China"},{"key":"10.1016\/j.antiviral.2016.11.006_bib55","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1086\/656315","article-title":"The membrane protein of severe acute respiratory syndrome coronavirus acts as a dominant immunogen revealed by a clustering region of novel functionally and structurally defined cytotoxic T-lymphocyte epitopes","volume":"202","author":"Liu","year":"2010","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.antiviral.2016.11.006_bib56","doi-asserted-by":"crossref","first-page":"11849","DOI":"10.1128\/JVI.01464-10","article-title":"Novel immunodominant peptide presentation strategy: a featured HLA-A*2402-restricted cytotoxic T-lymphocyte epitope stabilized by intrachain hydrogen bonds from severe acute respiratory syndrome coronavirus nucleocapsid protein","volume":"84","author":"Liu","year":"2010","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2016.11.006_bib57","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1258\/ebm.2010.010278","article-title":"Revival of the identification of cytotoxic T-lymphocyte epitopes for immunological diagnosis, therapy and vaccine development","volume":"236","author":"Liu","year":"2011","journal-title":"Exp. Biol. Med."},{"key":"10.1016\/j.antiviral.2016.11.006_bib58","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s13238-014-0060-1","article-title":"Characterization of human alphabetaTCR repertoire and discovery of D-D fusion in TCRbeta chains","volume":"5","author":"Liu","year":"2014","journal-title":"Protein Cell"},{"key":"10.1016\/j.antiviral.2016.11.006_bib59","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1086\/500469","article-title":"Two-year prospective study of the humoral immune response of patients with severe acute respiratory syndrome","volume":"193","author":"Liu","year":"2006","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.antiviral.2016.11.006_bib120","article-title":"Protective T-cell responses featured by concordant recognition of MERS-CoV-derived CD8+ T-cell epitopes and host MHC","author":"Liu","year":"2016","journal-title":"J. Immunol."},{"key":"10.1016\/j.antiviral.2016.11.006_bib60","doi-asserted-by":"crossref","first-page":"6606","DOI":"10.1016\/j.vaccine.2011.06.111","article-title":"Chimeric severe acute respiratory syndrome coronavirus (SARS-CoV) S glycoprotein and influenza matrix 1 efficiently form virus-like particles (VLPs) that protect mice against challenge with SARS-CoV","volume":"29","author":"Liu","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2016.11.006_bib61","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.vaccine.2007.11.092","article-title":"Chimeric coronavirus-like particles carrying severe acute respiratory syndrome coronavirus (SCoV) S protein protect mice against challenge with SCoV","volume":"26","author":"Lokugamage","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2016.11.006_bib62","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/nature12328","article-title":"Molecular basis of binding between novel human coronavirus MERS-CoV and its receptor CD26","volume":"500","author":"Lu","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2016.11.006_bib63","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.tim.2015.06.003","article-title":"Bat-to-human: spike features determining 'host jump' of coronaviruses SARS-CoV, MERS-CoV, and beyond","volume":"23","author":"Lu","year":"2015","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.antiviral.2016.11.006_bib121","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/1471-2172-10-61","article-title":"Identification of a novel conserved HLA-A*0201-restricted epitope from the spike protein of SARS-CoV","volume":"10","author":"Lv","year":"2009","journal-title":"BMC Immunol."},{"key":"10.1016\/j.antiviral.2016.11.006_bib64","doi-asserted-by":"crossref","first-page":"6150","DOI":"10.1128\/JVI.00106-08","article-title":"Priming of CD8+ T cells during central nervous system infection with a murine coronavirus is strain dependent","volume":"82","author":"MacNamara","year":"2008","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2016.11.006_bib65","doi-asserted-by":"crossref","first-page":"6338","DOI":"10.1016\/j.vaccine.2008.09.026","article-title":"A\u00a0SARS DNA vaccine induces neutralizing antibody and cellular immune responses in healthy adults in a Phase I clinical trial","volume":"26","author":"Martin","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2016.11.006_bib66","doi-asserted-by":"crossref","first-page":"4251","DOI":"10.1128\/JVI.03571-13","article-title":"Attenuation and restoration of severe acute respiratory syndrome coronavirus mutant lacking 2'-o-methyltransferase activity","volume":"88","author":"Menachery","year":"2014","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2016.11.006_bib67","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.virusres.2014.03.018","article-title":"Serological assays for emerging coronaviruses: challenges and pitfalls","volume":"194","author":"Meyer","year":"2014","journal-title":"Virus Res."},{"key":"10.1016\/j.antiviral.2016.11.006_bib68","doi-asserted-by":"crossref","first-page":"25359","DOI":"10.1038\/srep25359","article-title":"Comparative and kinetic analysis of viral shedding and immunological responses in MERS patients representing a broad spectrum of disease severity","volume":"6","author":"Min","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.antiviral.2016.11.006_bib69","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1600-065X.1998.tb01571.x","article-title":"The structure and function of CD26 in the T-cell immune response","volume":"161","author":"Morimoto","year":"1998","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.antiviral.2016.11.006_bib70","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1016\/j.vaccine.2016.02.063","article-title":"Memory T cell responses targeting the SARS coronavirus persist up to 11 years post-infection","volume":"34","author":"Ng","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2016.11.006_bib71","doi-asserted-by":"crossref","first-page":"12489","DOI":"10.1128\/JVI.01845-13","article-title":"Middle East respiratory syndrome coronavirus accessory protein 4a is a type I interferon antagonist","volume":"87","author":"Niemeyer","year":"2013","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2016.11.006_bib72","doi-asserted-by":"crossref","first-page":"10464","DOI":"10.1128\/JVI.05039-11","article-title":"Engineering T cells specific for a dominant severe acute respiratory syndrome coronavirus CD8 T cell epitope","volume":"85","author":"Oh","year":"2011","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2016.11.006_bib73","doi-asserted-by":"crossref","first-page":"3912","DOI":"10.1016\/j.vaccine.2009.04.001","article-title":"Synthetic peptides coupled to the surface of liposomes effectively induce SARS coronavirus-specific cytotoxic T lymphocytes and viral clearance in HLA-A*0201 transgenic mice","volume":"27","author":"Ohno","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2016.11.006_bib74","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.3201\/eid2112.151421","article-title":"Kinetics of serologic responses to MERS coronavirus infection in humans, South Korea","volume":"21","author":"Park","year":"2015","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.antiviral.2016.11.006_bib75","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.virol.2006.03.036","article-title":"Long-lived memory T lymphocyte responses against SARS coronavirus nucleocapsid protein in SARS-recovered patients","volume":"351","author":"Peng","year":"2006","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2016.11.006_bib122","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1002\/jmv.21571","article-title":"Characterization of cytotoxic T-lymphocyte epitopes and immune responses to SARS coronavirus spike DNA vaccine expressing the RGD-integrin-binding motif","volume":"81","author":"Poh","year":"2009","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.antiviral.2016.11.006_bib76","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/nature12005","article-title":"Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC","volume":"495","author":"Raj","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2016.11.006_bib77","doi-asserted-by":"crossref","first-page":"20441","DOI":"10.2807\/1560-7917.ES2013.18.14.20441","article-title":"Specific serology for emerging human coronaviruses by protein microarray","volume":"18","author":"Reusken","year":"2013","journal-title":"Euro Surveil"},{"key":"10.1016\/j.antiviral.2016.11.006_bib78","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.3201\/eid2008.140590","article-title":"Geographic distribution of MERS coronavirus among dromedary camels, Africa","volume":"20","author":"Reusken","year":"2014","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.antiviral.2016.11.006_bib123","doi-asserted-by":"crossref","first-page":"4010","DOI":"10.4049\/jimmunol.1301507","article-title":"Defining CD8+ T cell determinants during human viral infection in populations of Asian ethnicity","volume":"191","author":"Rivino","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.antiviral.2016.11.006_bib79","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1107\/S1744309108012396","article-title":"Structure of a SARS coronavirus-derived peptide bound to the human major histocompatibility complex class I molecule HLA-B*1501","volume":"64","author":"Roder","year":"2008","journal-title":"Acta Crystallogr. Sect. F. Struct. Biol. Cryst. Commun."},{"key":"10.1016\/j.antiviral.2016.11.006_bib80","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1126\/science.1085952","article-title":"Characterization of a novel coronavirus associated with severe acute respiratory syndrome","volume":"300","author":"Rota","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2016.11.006_bib81","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.cell.2010.05.037","article-title":"A\u00a0comprehensive comparison of transmembrane domains reveals organelle-specific properties","volume":"142","author":"Sharpe","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.antiviral.2016.11.006_bib82","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1128\/JVI.69.2.684-694.1995","article-title":"Mouse hepatitis virus-specific cytotoxic T lymphocytes protect from lethal infection without eliminating virus from the central nervous system","volume":"69","author":"Stohlman","year":"1995","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2016.11.006_bib83","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1016\/S0140-6736(15)60859-5","article-title":"MERS in South Korea and China: a potential outbreak threat?","volume":"385","author":"Su","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.antiviral.2016.11.006_bib84","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.tim.2016.03.003","article-title":"Epidemiology, genetic recombination, and pathogenesis of coronaviruses","volume":"24","author":"Su","year":"2016","journal-title":"Trend Microbiol."},{"key":"10.1016\/j.antiviral.2016.11.006_bib85","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s13238-014-0041-4","article-title":"A\u00a0new unconventional HLA-A2-restricted epitope from HBV core protein elicits antiviral cytotoxic T lymphocytes","volume":"5","author":"Sun","year":"2014","journal-title":"Protein Cell"},{"key":"10.1016\/j.antiviral.2016.11.006_bib86","doi-asserted-by":"crossref","first-page":"645","DOI":"10.3851\/IMP2735","article-title":"Evaluation of protective efficacy of the synthetic peptide vaccine containing the T-helper 1 epitope with CpG oligodeoxynucleotide against feline infectious peritonitis virus infection in cats","volume":"19","author":"Takano","year":"2014","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.antiviral.2016.11.006_bib87","doi-asserted-by":"crossref","first-page":"7264","DOI":"10.4049\/jimmunol.0903490","article-title":"Lack of peripheral memory B cell responses in recovered patients with severe acute respiratory syndrome: a six-year follow-up study","volume":"186","author":"Tang","year":"2011","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.antiviral.2016.11.006_bib88","doi-asserted-by":"crossref","first-page":"E2018","DOI":"10.1073\/pnas.1402074111","article-title":"Identification of human neutralizing antibodies against MERS-CoV and their role in virus adaptive evolution","volume":"111","author":"Tang","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.antiviral.2016.11.006_bib89","first-page":"S103","article-title":"From SARS coronavirus to novel animal and human coronaviruses","volume":"5","author":"To","year":"2013","journal-title":"J.\u00a0Thorac. Dis."},{"key":"10.1016\/j.antiviral.2016.11.006_bib90","doi-asserted-by":"crossref","first-page":"5245","DOI":"10.4049\/jimmunol.1400111","article-title":"Structural and functional correlates of enhanced antiviral immunity generated by heteroclitic CD8 T cell epitopes","volume":"192","author":"Trujillo","year":"2014","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.antiviral.2016.11.006_bib124","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.bbrc.2006.03.152","article-title":"HLA-A*0201 T-cell epitopes in severe acute respiratory syndrome (SARS) coronavirus nucleocapsid and spike proteins","volume":"344","author":"Tsao","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.antiviral.2016.11.006_bib91","doi-asserted-by":"crossref","first-page":"e35421","DOI":"10.1371\/journal.pone.0035421","article-title":"Immunization with SARS coronavirus vaccines leads to pulmonary immunopathology on challenge with the SARS virus","volume":"7","author":"Tseng","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.antiviral.2016.11.006_bib92","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.coviro.2016.01.011","article-title":"Middle East respiratory syndrome and severe acute respiratory syndrome","volume":"16","author":"Vijay","year":"2016","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.antiviral.2016.11.006_bib93","doi-asserted-by":"crossref","first-page":"8651","DOI":"10.1128\/JVI.00614-15","article-title":"Protective efficacy of recombinant modified vaccinia virus ankara delivering Middle East respiratory syndrome coronavirus spike glycoprotein","volume":"89","author":"Volz","year":"2015","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2016.11.006_bib125","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1182\/blood-2003-11-4072","article-title":"Identification of an HLA-A*0201-restricted CD8(+) T-cell epitope SSp-1 of SARS-CoV spike protein","volume":"104","author":"Wang","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.antiviral.2016.11.006_bib94","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.chom.2014.08.009","article-title":"Bat origins of MERS-CoV supported by bat coronavirus HKU4 usage of human receptor CD26","volume":"16","author":"Wang","year":"2014","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.antiviral.2016.11.006_bib95","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.antiviral.2016.07.015","article-title":"MERS-CoV spike protein: targets for vaccines and therapeutics","volume":"133","author":"Wang","year":"2016","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2016.11.006_bib96","first-page":"219","article-title":"Serological study of an imported case of Middle East respiratory syndrome and his close contacts in China, 2015","volume":"29","author":"Wang","year":"2016","journal-title":"Biomed. Environ. Sci."},{"key":"10.1016\/j.antiviral.2016.11.006_bib97","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01280-15","article-title":"Origin and possible genetic recombination of the Middle East respiratory syndrome coronavirus from the first imported case in China: phylogenetics and coalescence analysis","volume":"6","author":"Wang","year":"2015","journal-title":"mBio"},{"key":"10.1016\/j.antiviral.2016.11.006_bib126","doi-asserted-by":"crossref","first-page":"5612","DOI":"10.1128\/JVI.78.11.5612-5618.2004","article-title":"T-cell epitopes in severe acute respiratory syndrome (SARS) coronavirus spike protein elicit a specific T-cell immune response in patients who recover from SARS","volume":"78","author":"Wang","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2016.11.006_bib98","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.chom.2015.09.013","article-title":"MERS, SARS, and Ebola: the role of super-spreaders in infectious disease","volume":"18","author":"Wong","year":"2015","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.antiviral.2016.11.006_bib99","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1128\/JCM.42.5.2306-2309.2004","article-title":"Detection of specific antibodies to severe acute respiratory syndrome (SARS) coronavirus nucleocapsid protein for serodiagnosis of SARS coronavirus pneumonia","volume":"42","author":"Woo","year":"2004","journal-title":"J.\u00a0Clin. Microbiol."},{"key":"10.1016\/j.antiviral.2016.11.006_bib100","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1038\/gt.2009.92","article-title":"Immune responses to T-cell epitopes of SARS CoV-N protein are enhanced by N immunization with a chimera of lysosome-associated membrane protein","volume":"16","author":"Yang","year":"2009","journal-title":"Gene Ther."},{"key":"10.1016\/j.antiviral.2016.11.006_bib101","doi-asserted-by":"crossref","first-page":"2740","DOI":"10.1099\/vir.0.82839-0","article-title":"Persistent memory CD4+ and CD8+ T-cell responses in recovered severe acute respiratory syndrome (SARS) patients to SARS coronavirus M antigen","volume":"88","author":"Yang","year":"2007","journal-title":"J.\u00a0Gen. Virol."},{"key":"10.1016\/j.antiviral.2016.11.006_bib102","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.clim.2006.05.002","article-title":"Long-lived effector\/central memory T-cell responses to severe acute respiratory syndrome coronavirus (SARS-CoV) S antigen in recovered SARS patients","volume":"120","author":"Yang","year":"2006","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.antiviral.2016.11.006_bib103","doi-asserted-by":"crossref","first-page":"17554","DOI":"10.1038\/srep17554","article-title":"Middle East respiratory syndrome coronavirus ORF4b protein inhibits type I interferon production through both cytoplasmic and nuclear targets","volume":"5","author":"Yang","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.antiviral.2016.11.006_bib104","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1056\/NEJMoa1211721","article-title":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia","volume":"367","author":"Zaki","year":"2012","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.antiviral.2016.11.006_bib105","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1586\/14760584.2014.912134","article-title":"Current advancements and potential strategies in the development of MERS-CoV vaccines","volume":"13","author":"Zhang","year":"2014","journal-title":"Expert Rev. Vac."},{"key":"10.1016\/j.antiviral.2016.11.006_bib106","doi-asserted-by":"crossref","first-page":"8304","DOI":"10.1128\/JVI.00539-15","article-title":"Frequency, private specificity, and cross-reactivity of preexisting hepatitis C virus (HCV)-Specific CD8+ T cells in HCV-seronegative individuals: implications for vaccine responses","volume":"89","author":"Zhang","year":"2015","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2016.11.006_bib107","doi-asserted-by":"crossref","first-page":"6079","DOI":"10.1128\/JVI.02568-06","article-title":"Identification and characterization of dominant helper T-cell epitopes in the nucleocapsid protein of severe acute respiratory syndrome coronavirus","volume":"81","author":"Zhao","year":"2007","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2016.11.006_bib108","doi-asserted-by":"crossref","first-page":"6117","DOI":"10.1128\/JVI.00446-15","article-title":"Passive immunotherapy with dromedary immune serum in an experimental animal model for Middle East respiratory syndrome coronavirus infection","volume":"89","author":"Zhao","year":"2015","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2016.11.006_bib109","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/j.immuni.2016.05.006","article-title":"Airway memory CD4(+) T cells mediate protective immunity against emerging respiratory coronaviruses","volume":"44","author":"Zhao","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.antiviral.2016.11.006_bib110","doi-asserted-by":"crossref","first-page":"9318","DOI":"10.1128\/JVI.01049-10","article-title":"T\u00a0cell responses are required for protection from clinical disease and for virus clearance in severe acute respiratory syndrome coronavirus-infected mice","volume":"84","author":"Zhao","year":"2010","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2016.11.006_bib111","doi-asserted-by":"crossref","first-page":"6670","DOI":"10.1016\/j.vaccine.2011.06.100","article-title":"The immune responses of HLA-A*0201 restricted SARS-CoV S peptide-specific CD8(+) T cells are augmented in varying degrees by CpG ODN, PolyI: C and R848","volume":"29","author":"Zhao","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2016.11.006_bib112","doi-asserted-by":"crossref","first-page":"6666","DOI":"10.1016\/j.vaccine.2010.08.013","article-title":"CD8+ T cell response in HLA-A*0201 transgenic mice is elicited by epitopes from SARS-CoV S protein","volume":"28","author":"Zhao","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2016.11.006_bib113","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.virol.2005.01.050","article-title":"Identification of murine CD8 T cell epitopes in codon-optimized SARS-associated coronavirus spike protein","volume":"335","author":"Zhi","year":"2005","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2016.11.006_bib114","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1093\/infdis\/jit504","article-title":"Active replication of Middle East respiratory syndrome coronavirus and aberrant induction of inflammatory cytokines and chemokines in human macrophages: implications for pathogenesis","volume":"209","author":"Zhou","year":"2014","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.antiviral.2016.11.006_bib115","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.4049\/jimmunol.177.4.2138","article-title":"Screening and identification of severe acute respiratory syndrome-associated coronavirus-specific CTL epitopes","volume":"177","author":"Zhou","year":"2006","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.antiviral.2016.11.006_bib116","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1126\/science.1192819","article-title":"Structural basis for broad and potent neutralization of HIV-1 by antibody VRC01","volume":"329","author":"Zhou","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2016.11.006_bib117","doi-asserted-by":"crossref","first-page":"e109","DOI":"10.1371\/journal.ppat.0030109","article-title":"Coronavirus non-structural protein 1 is a major pathogenicity factor: implications for the rational design of coronavirus vaccines","volume":"3","author":"Zust","year":"2007","journal-title":"PLoS Pathog."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354216304016?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354216304016?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T10:48:32Z","timestamp":1749725312000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354216304016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":126,"alternative-id":["S0166354216304016"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2016.11.006","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"T-cell immunity of SARS-CoV: Implications for vaccine development against MERS-CoV","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2016.11.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}